13 results on '"Oue, N."'
Search Results
2. Annexin A10 is involved in the induction of pancreatic duodenal homeobox‑1 in gastric cancer tissue, cells and organoids.
- Author
-
Ishikawa A, Sakamoto N, Honma R, Taniyama D, Fukada K, Hattori T, Sentani K, Oue N, Yanagihara K, Tanabe K, Ohdan H, and Yasui W
- Subjects
- Adult, Aged, Aged, 80 and over, Biomarkers, Tumor metabolism, Cell Line, Tumor, Female, Gene Expression Regulation, Neoplastic, Humans, Male, Middle Aged, Annexins metabolism, Homeodomain Proteins metabolism, Organoids metabolism, Stomach Neoplasms metabolism, Trans-Activators metabolism
- Abstract
Gastric cancer (GC) is the third most common cause of cancer‑related death in the world. Annexin A10 (ANXA10), a member of the Annexin family, is a calcium‑/phospholipid‑binding protein; however, little is known concerning its functions. It is still unclear what molecule is involved in the induction of ANXA10. In the present study, we performed immunohistochemistry to evaluate the expression of ANXA10, pancreatic and duodenal homeobox‑1 (PDX1) and mucin phenotype markers in 130 GC samples. ANXA10 was detected in 63 (48%) of the 130 GC cases and loss of ANXA10 was significantly correlated with disease progression and poor clinical outcomes in GC. PDX1 was significantly correlated with ANXA10 in GC cases and cell lines. Although PDX1 was not significantly correlated with the GC cases with any of the mucin phenotypes, ANXA10 was preferentially detected in the GC cases with the gastric mucin phenotype. As a further investigation, we generated organoids derived from human GC and identified the duplication of the mucin phenotypes of GC by immunohistochemistry. The repression effect on cell growth that was observed in the ANXA10‑knockdown cell lines was also clearly observed in the human gastric organoids. We demonstrated that the expression of ANXA10 was correlated with the gastric mucin phenotype and ANXA10 was involved in the induction of PDX1 expression in GC. We also provided evidence that GC organoids represent a powerful tool for scrutinizing the biology of GC, especially with regard to the mucin phenotype.
- Published
- 2020
- Full Text
- View/download PDF
3. Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.
- Author
-
Sekino Y, Sakamoto N, Ishikawa A, Honma R, Shigematsu Y, Hayashi T, Sentani K, Oue N, Teishima J, Matsubara A, and Yasui W
- Subjects
- Aged, Aged, 80 and over, Antineoplastic Agents therapeutic use, Carcinoma, Transitional Cell drug therapy, Carcinoma, Transitional Cell pathology, Cell Line, Tumor, Cell Proliferation genetics, Cisplatin therapeutic use, Gene Expression Regulation, Neoplastic, Gene Knockdown Techniques, Humans, Male, Middle Aged, RNA Interference, RNA, Untranslated genetics, Signal Transduction genetics, Urinary Bladder pathology, Urinary Bladder Neoplasms drug therapy, Urinary Bladder Neoplasms pathology, Antineoplastic Agents pharmacology, Carcinoma, Transitional Cell genetics, Cisplatin pharmacology, Drug Resistance, Neoplasm genetics, RNA, Untranslated metabolism, Receptors, Androgen metabolism, Urinary Bladder Neoplasms genetics
- Abstract
Cisplatin (CDDP)‑based combination chemotherapy is the standard for muscle‑invasive bladder cancer (MIBC). However, nearly all patients undergoing CDDP chemotherapy become refractory due to the development of CDDP resistance. Therefore, clarification of the mechanisms of CDDP resistance is urgently needed. The transcribed ultraconserved regions (T‑UCRs) are a novel class of non‑coding RNAs that are highly conserved across species and are associated with carcinogenesis and cancer progression. In addition, emerging evidence has shown the involvement of androgen receptor (AR) signals in urothelial carcinoma (UC) progression. The aim of the present study was to investigate the expression of transcribed ultraconserved region Uc.63+, and to analyze the effects of Uc.63+ on AR expression and CDDP resistance in UC. Quantitative reverse transcription‑polymerase chain reaction (qRT‑PCR) revealed that the expression of Uc.63+ was higher in UC tissues than that in non‑neoplastic bladder tissues and 15 types of normal tissue. An MTT assay revealed that Uc.63+ was involved in cell proliferation. Western blotting demonstrated that the expression of AR was disrupted by the overexpression or knockdown of Uc.63+ in AR‑positive UMUC3 cells. Furthermore, knockdown of Uc.63+ increased sensitivity to CDDP in UMUC3 cells. Conversely, overexpression of Uc.63+ had no effect on CDDP sensitivity in AR‑negative RT112 cells. Additionally, we observed that the expression of Uc.63+ was increased in CDDP‑resistant UMUC3 cells (UMUC3‑CR) in comparison with that in parental UMUC3 cells. Knockdown of Uc.63+ re‑sensitized the UMUC3‑CR cells to CDDP. These results indicated that Uc.63+ may be a promising therapeutic target to overcome CDDP resistance in UC.
- Published
- 2019
- Full Text
- View/download PDF
4. Induction of KIFC1 expression in gastric cancer spheroids.
- Author
-
Oue N, Mukai S, Imai T, Pham TT, Oshima T, Sentani K, Sakamoto N, Yoshida K, and Yasui W
- Subjects
- Aldehyde Dehydrogenase genetics, Cell Line, Tumor, Humans, Kaplan-Meier Estimate, Neoplasm Staging methods, Neoplastic Stem Cells metabolism, Neoplastic Stem Cells pathology, RNA, Small Interfering genetics, Retrospective Studies, Spheroids, Cellular pathology, Stomach Neoplasms pathology, Transcriptome genetics, Kinesins genetics, Spheroids, Cellular metabolism, Stomach Neoplasms genetics
- Abstract
Gastric cancer (GC) is one of the most common human cancers. Spheroid colony formation is an effective model for characterization of cancer stem cells. However, gene expression profiles of spheroid colonies obtained from GC cells have not been examined. We performed microarray analyses by Human Genome U133 Plus 2.0 Array in spheroid body-forming and parental cells from MKN-45 and MKN-74 GC cell lines. Kinesin family member C1 (KIFC1) was expressed >2-fold higher in spheroid body-forming cells than in parental cells in both GC lines. Both the number and size of spheres from MKN-45 cells were significantly reduced upon KIFC1 siRNA-transfection compared with negative control siRNA-transfection. Immunohistochemical analysis of 114 GC tissue samples revealed that 42 (37%) of GC cases were positive for KIFC1 expression. GC cases positive for KIFC1 were found more frequently in stage III/IV cases than in stage I/II cases. GC cases positive for KIFC1 were found more frequently in intestinal type GC cases than in diffuse type GC cases. Furthermore, KIFC1-positive GC cases showed high Ki-67 labeling index. Kaplan-Meier analysis demonstrated that KIFC1 expression was not associated with survival. We found positive expression of KIFC1 in CD44‑positive GC and aldehyde dehydrogenase 1 (ALDH1)-positive GC cells. Our results showed that KIFC1 is overexpressed in GC. Since knockdown of KIFC1 inhibited sphere formation, KIFC1 likely plays an important role in cancer stem cells.
- Published
- 2016
- Full Text
- View/download PDF
5. MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer.
- Author
-
Naito Y, Yasuno K, Tagawa H, Sakamoto N, Oue N, Yashiro M, Sentani K, Goto K, Shinmei S, Oo HZ, Yanagihara K, Hirakawa K, and Yasui W
- Subjects
- Adenocarcinoma, Scirrhous pathology, Case-Control Studies, Cell Line, Tumor, Female, Humans, Male, Middle Aged, Neoplasm Grading, Neoplasm Staging, Prognosis, Real-Time Polymerase Chain Reaction, Stomach Neoplasms pathology, Adenocarcinoma, Scirrhous genetics, Biomarkers, Tumor genetics, Gene Expression Regulation, Neoplastic, MicroRNAs genetics, Stomach Neoplasms genetics
- Abstract
Gastric cancer (GC) is one of the most common malignancies worldwide. In particular, scirrhous type GC is highly metastatic and is characterized clinically by rapid disease progression and poor prognosis. MicroRNAs (miRNAs) play crucial roles in cancer development and progression. We previously demonstrated by microarray analysis that microRNA-145 (miR-145) is one of the more highly expressed miRNAs in scirrhous type GC vs. non-scirrhous types of GC. In the present study, we investigated the role of miR-145 in scirrhous type GC. The expression levels of miR-145 assessed by quantitative RT-PCR were higher in scirrhous type GC tissue samples than in non-scirrhous type GC and corresponding normal tissues. GC patients with high miR-145 expression were at a more advanced tumor stage (P=0.0156) and had more scirrhous type histology (P=0.0054) than those with low miR-145 expression. Furthermore, miR-145 expression was significantly associated with poor prognosis in GC patients (P=0.0438). miR-145 expression was localized in stromal fibroblasts of scirrhous type GC but not in cancer cells. miR-145 was induced by treatment by transforming growth factor-β, and it enhanced the expression of α-smooth muscle actin, a marker of myofibroblasts, in both normal gastric fibroblasts and cancer-associated fibroblasts. These data suggest that miR-145 may contribute to the progression of scirrhous type GC by regulating activation of peri-tumoral fibroblasts.
- Published
- 2014
- Full Text
- View/download PDF
6. Overexpression of ZDHHC14 promotes migration and invasion of scirrhous type gastric cancer.
- Author
-
Oo HZ, Sentani K, Sakamoto N, Anami K, Naito Y, Uraoka N, Oshima T, Yanagihara K, Oue N, and Yasui W
- Subjects
- Adenocarcinoma, Scirrhous genetics, Aged, Cell Adhesion, Cell Line, Tumor, Cell Movement, Disease Progression, Female, Gene Expression Regulation, Neoplastic, Gene Knockdown Techniques, Humans, Male, Middle Aged, Neoplasm Invasiveness pathology, Stomach Neoplasms genetics, Up-Regulation, Acyltransferases genetics, Acyltransferases metabolism, Adenocarcinoma, Scirrhous pathology, Neoplasm Invasiveness genetics, Stomach Neoplasms pathology
- Abstract
Scirrhous type gastric cancer is highly aggressive and has a poorer prognosis than many other types of gastric carcinoma, due to its characteristic rapid cancer cell infiltration and proliferation, extensive stromal fibrosis, and frequent peritoneal dissemination. The aim of the present study was to identify novel prognostic markers or therapeutic targets for scirrhous type gastric cancer. We reviewed a list of genes with upregulated expression in scirrhous type gastric cancer and compared their expression with that in normal stomach from our previous Escherichia coli (E. coli) ampicillin secretion-trap (CAST) analysis. We focused on the ZDHHC14 gene, which encodes zinc finger, DHHC-type containing 14 protein. qRT-PCR analysis of ZDHHC14 in 41 gastric cancer cases revealed that compared to mRNA levels in normal non-neoplastic gastric mucosa, ZDHHC14 mRNA was overexpressed in 27% of gastric cancer tissue samples. The overexpression of ZDHHC14 was significantly associated with depth of tumor invasion, undifferentiated histology and scirrhous pattern. The invasiveness of ZDHHC14-knockdown HSC-44PE and 44As3 gastric cancer cells was decreased in comparison with that of the negative control siRNA-transfected cells, together with downregulation of MMP-17 mRNA. Integrins α5 and β1 were also downregulated in ZDHHC14-knockdown 44As3 cells. Forced expression of ZDHHC14 activated gastric cancer cell migration and invasion in vitro. These results indicate that ZDHHC14 is involved in tumor progression in patients with scirrhous type gastric cancer.
- Published
- 2014
- Full Text
- View/download PDF
7. New molecular staging with G-factors (VEGF-C and Reg IV) by supplementing TNM classification in colorectal cancers.
- Author
-
Sawada T, Yashiro M, Sentani K, Oue N, Yasui W, Miyazaki K, Kai K, Fujita H, Nakamura K, Maeda K, Kakeji Y, Natsugoe S, Shirabe K, Nomura S, Shimada Y, Tomita N, Hirakawa K, and Maehara Y
- Subjects
- Claudins biosynthesis, Colorectal Neoplasms pathology, Disease-Free Survival, Gene Expression Regulation, Neoplastic, Granulocyte Colony-Stimulating Factor biosynthesis, Humans, Lectins, C-Type genetics, Matrix Metalloproteinase 7 biosynthesis, Neoplasm Recurrence, Local pathology, Neoplasm Staging, Pancreatitis-Associated Proteins, Vascular Endothelial Growth Factor A biosynthesis, Vascular Endothelial Growth Factor A genetics, Vascular Endothelial Growth Factor C genetics, Colorectal Neoplasms genetics, Colorectal Neoplasms surgery, Lectins, C-Type biosynthesis, Neoplasm Recurrence, Local genetics, Vascular Endothelial Growth Factor C biosynthesis
- Abstract
Staging classification of colorectal cancers is performed by the UICC/TNM classification system, which is the global gold standard. However, we often experience in clinical practice that there are considerable differences in prognoses between patients who have the same classification particularly in stage II and III cancers. The aim of this study was to propose a new TNM-G classification to predict prognosis and recurrence by supplementing the conventional TNM classification. A total of 220 cases of colorectal cancer, including 77 at stage II and 143 at stage III, were registered from four independent facilities. Immunohistochemical staining for 7 molecules, such as p53, vascular endothelial growth factor (VEGF)-A, VEGF-C, regenerating islet-derived family, member 4 (Reg IV), olfactomedin 4, Claudin-18 and matrix metalloproteinase-7 (MMP‑7), was performed to investigate the correlation between clinicopathological factors and expression of each molecule. Based on the results, no significant correlation was observed between the immunostaining expression of these 7 factors and recurrence in total colorectal cancer. Recurrence in stage II (77 cases) was significantly higher in cases positive for Reg IV expression (P=0.042). On analysis of overall survival (OS) and disease‑free survival (DFS), VEGF-C and Reg IV expression had a correlation with poor prognosis, therefore, these factors were selected and applied to G-factor classifications so that cases negative for both could be classified as G0, cases positive for either of the factors could be classified as G1, and cases positive for both factors could be classified as G2. While no significant correlation was observed in the recurrence rates between G0 and G2, OS and DFS in stage II cases were significantly poorer for G2 cases in comparison with G0 or G1 cases. The survival curves of OS and DFS in stage II G2 were similar to that of stage III cases. According to these results, prognosis of VEGF-C/Reg IV both positive G2 cases in stage II colorectal cancer was found to be almost equal to the poor survival in stage III cases, and the advancement of one stage up migration based on G-factors may be supposed to be highly feasible for clinical application. In conclusion, the combination of VEGF-C and Reg IV may be a promising factor for clinical staging to supplement the classical TNM classification system, and it may suggest a good indication of adjuvant chemotherapy for G2 cases in stage II colorectal cancers.
- Published
- 2013
- Full Text
- View/download PDF
8. Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker.
- Author
-
Hayashi T, Matsubara A, Ohara S, Mita K, Hasegawa Y, Usui T, Arihiro K, Norimura S, Sentani K, Oue N, and Yasui W
- Subjects
- Aged, Aged, 80 and over, Blotting, Western, Carcinoma, Renal Cell blood, Chromogranin A biosynthesis, Enzyme-Linked Immunosorbent Assay, Humans, Immunohistochemistry, Kidney Neoplasms blood, Male, Middle Aged, Mucin-2 biosynthesis, Pancreatitis-Associated Proteins, Sensitivity and Specificity, Synaptophysin biosynthesis, Urinary Bladder Neoplasms blood, Biomarkers, Tumor blood, Lectins, C-Type blood, Prostatic Neoplasms blood, Urogenital Neoplasms blood
- Abstract
Regenerating islet-derived family, member 4 (Reg IV) is a candidate marker for cancer and inflammatory bowel disease and is associated with neuroendocrine and intestinal differentiation. We have reported that 14% of prostate cancer (PCa) cases are positive for Reg IV by immunohistochemistry. In the present study, we performed immunohistochemical analysis of Reg IV in other major urological cancers, including 101 renal cell carcinoma (RCC), and 95 urothelial carcinoma (UC) of urinary bladder by immunohistochemistry. We also investigated neuroendocrine differentiation by chromogranin A and synaptophysin staining along with intestinal differentiation by MUC2 staining. Immunohistochemical analysis of Reg IV revealed no expression of Reg IV in RCC, and only one case (1%) of UC expressed Reg IV. Neither neuroendocrine nor intestinal differentiation was found in RCC. Among 95 UC cases, neuroendocrine differentiation was detected in 13 cases (14%), and intestinal differentiation was observed in 33 cases (35%). In one Reg IV-positive UC case, MUC2 staining was observed. Since Reg IV expression was frequently found in PCa, we also measured Reg IV levels in sera from patients with PCa by enzyme-linked immunosorbent assay. The serum Reg IV concentration in PCa patients (n=38, mean +/- SE, 1.69+/-0.16 ng/ml) was significantly higher than that in control individuals (n=40, 1.28+/-0.11 ng/ml, P=0.0199, Mann-Whitney U test). The sensitivity and specificity for detection of PCa were 34% (13/38) and 90% (36/40), respectively. These results suggest that among major urologic cancers, Reg IV is expressed frequently in PCa, and that serum Reg IV represents a novel biomarker for PCa.
- Published
- 2009
9. Positive immunohistochemical staining of gammaH2AX is associated with tumor progression in gastric cancers from radiation-exposed patients.
- Author
-
Sentani K, Oue N, Sakamoto N, Nishisaka T, Fukuhara T, Matsuura H, and Yasui W
- Subjects
- Fluorescent Antibody Technique, Humans, Immunohistochemistry, Neoplasms, Radiation-Induced metabolism, Neoplasms, Radiation-Induced pathology, Nuclear Weapons, Radioactive Fallout adverse effects, Stomach Neoplasms metabolism, Stomach Neoplasms pathology, Survivors, DNA Breaks, Double-Stranded radiation effects, Histones metabolism, Neoplasms, Radiation-Induced genetics, Stomach Neoplasms genetics
- Abstract
To elucidate the mechanism of radiation-induced cancers, molecular analysis of cancers in atomic bomb (A-bomb) exposure is important. DNA double-strand breaks (DSBs) are thought to be caused by the deleterious effects of ionizing radiation, and gammaH2AX (serine 139 phosphorylated form of histone H2AX) is reported to be a significant marker for DSBs. In the present study, we performed immunohistochemical analysis of gammaH2AX in gastric cancers (GCs) from 66 exposed and 47 non-exposed patients who developed GC after the bombing. Of the 47 GCs from non-exposed patients, 6 (13%) cases showed nuclear positive staining for gammaH2AX, whereas of the 66 GCs from exposed patients, 20 (30%) cases were positive (P=0.0405). However, among stage I GC, there was no significant difference in gammaH2AX expression frequency between exposed patients and non-exposed patients. Among exposed patients, stage II-IV cases were more frequently positive for gammaH2AX than stage I cases (P=0.0197). Among GCs from non-exposed patients, gammaH2AX staining showed no significant association with Lauren's classification, depth of invasion, lymph node metastasis or TNM stage. These results suggest that the characteristics of tumor cells differ between GCs from exposed and non-exposed patients. DSBs may be involved in progression of GC in exposed patients.
- Published
- 2008
10. Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer.
- Author
-
Suzuki T, Yoshida K, Wada Y, Hamai Y, Sentani K, Oue N, and Yasui W
- Subjects
- Antigens, Neoplasm, Antineoplastic Agents therapeutic use, Blotting, Western, Cell Line, Tumor, Cell Proliferation drug effects, DNA Methylation, Docetaxel, Drug Resistance, Neoplasm genetics, Gene Expression Regulation, Neoplastic, Humans, Immunohistochemistry, Melanoma-Specific Antigens, Neoplasm Proteins metabolism, Neoplasm Recurrence, Local, Polymerase Chain Reaction methods, Predictive Value of Tests, Prognosis, Stomach Neoplasms genetics, Stomach Neoplasms metabolism, Transfection, Neoplasm Proteins genetics, Paclitaxel therapeutic use, Stomach Neoplasms drug therapy, Taxoids therapeutic use
- Abstract
Melanoma-associated antigen (MAGE) genes are cancer-testis antigen genes that serve as immunotherapy targets in several human cancers. Previous studies have revealed that the forced expression of MAGE genes induces a paclitaxel-resistant phenotype. In the present study, we examined whether the expression of MAGE-A1 could predict the response of advanced and recurrent gastric cancers (GCs) to taxan (doce-taxel or paclitaxel)-based chemotherapy. The expression of MAGE-A1 was analyzed by immunostaining in 41 primary GC samples. DNA demethylation was assessed by methylation-specific polymerase chain reaction and the effect of the forced expression of MAGE-A1 on drug resistance to taxan drugs was monitored by MTT assay. The expression of MAGE-A1 in primary GC was observed in 4 (9.8%) of 41 cases. All 4 patients with MAGE-A1-positive GC showed progressive disease, whereas MAGE-A1 expression was not detected in any of the 23 patients showing partial response (P=0.0302). There was no association between MAGE-A1 gene demethylation and response to chemotherapy (P=0.7245). The forced MAGE-A1 expression in the TMK-1 GC cell line increased the sensitivity to paclitaxel and docetaxel. These results suggest that although MAGE-A1 does not participate directly in the drug-resistant phenotype, the expression of MAGE-A1 could be a marker for the prediction of resistance to taxan-based chemotherapies in patients with GC.
- Published
- 2007
11. A single nucleotide polymorphism in the extracellular domain of TRAIL receptor DR4 at nucleotide 626 in gastric cancer patients in Japan.
- Author
-
Kuraoka K, Matsumura S, Sanada Y, Nakachi K, Imai K, Eguchi H, Matsusaki K, Oue N, Nakayama H, and Yasui W
- Subjects
- Adenocarcinoma genetics, Adenocarcinoma metabolism, Aged, Case-Control Studies, DNA, Neoplasm genetics, DNA, Neoplasm isolation & purification, Female, Gene Frequency, Genotype, Humans, Immunohistochemistry, Japan, Lymphatic Metastasis, Male, Middle Aged, Mutation, Missense, Neoplasm Invasiveness, Neoplasm Staging, Polymerase Chain Reaction, Polymorphism, Restriction Fragment Length, Receptors, TNF-Related Apoptosis-Inducing Ligand, Receptors, Tumor Necrosis Factor analysis, Stomach Neoplasms genetics, Stomach Neoplasms metabolism, Adenocarcinoma pathology, Polymorphism, Single Nucleotide, Receptors, Tumor Necrosis Factor genetics, Stomach Neoplasms pathology
- Abstract
Death receptor 4 (DR4) is a member of the tumor necrosis factor-related apoptosis-inducing ligand receptor genes. A single nucleotide polymorphism (Thr or Arg, C or G) in the extracellular domain was reported to be associated with a risk of lung cancer, head and neck cancer, and bladder cancer. In this study, we examined the association between the DR4 polymorphism and gastric cancer. The Thr/Thr, Thr/Arg and Arg/Arg genotypes were found in 250 (91.2%), 23 (8.4%) and 1 (0.4%) of 274 gastric cancer patients and in 317 (92.2%), 21 (6.1%) and 6 (1.7%) of 344 control subjects, respectively. The OR of Thr/Arg or Arg/Arg genotype did not reveal a significantly enhanced risk of 1.13 (95% CI, 0.63-2.00) compared to Thr/Thr genotype, suggesting that the DR4 polymorphism did not modify the risk of gastric cancer. In patients, no association between the genotype and clinicopathological characteristics (depth of invasion, lymph node metastasis, distant metastasis, stage and grade of differentiation) of gastric carcinoma was found. DR4 was constantly expressed in gastric carcinoma, but not in non-neoplastic gastric epithelium in immunohistochemistry. In conclusion, a Thr to Arg single nucleotide polymorphism in the extracellular domain of DR4 could not be associated with the development and progression of gastric cancer.
- Published
- 2005
12. Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma.
- Author
-
Kuwai T, Kitadai Y, Tanaka S, Kuroda T, Ochiumi T, Matsumura S, Oue N, Yasui W, Kaneyasu M, Tanimoto K, Nishiyama M, and Chayama K
- Subjects
- Case-Control Studies, Cell Hypoxia, DNA, Neoplasm genetics, Female, Humans, Hypoxia-Inducible Factor 1, alpha Subunit, Male, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Polymerase Chain Reaction, Polymorphism, Single-Stranded Conformational, RNA, Messenger metabolism, Adenocarcinoma genetics, Colorectal Neoplasms genetics, Polymorphism, Single Nucleotide genetics, Transcription Factors genetics
- Abstract
Colorectal carcinoma is one of the most common malignancies in the world, and its incidence has increased in recent years. We have reported that expression of hypoxia-inducible factor (HIF)-1alpha correlates with expression of vascular endothelial growth factor (VEGF), tumor stage, lymphatic invasion, venous invasion, and liver metastasis. It has also been reported that a single nucleotide polymorphism (SNP) in exon 12 of HIF-1alpha gene is present in renal cell carcinoma and head and neck squamous cell carcinoma patients. We investigated the C1772T polymorphism in colorectal cancer patients and healthy control subjects to clarify the mechanism of HIF-1alpha activation in colorectal carcinoma. The exon 12 genotype was not associated with sex or age. The distribution of HIF-1alpha genotypes in controls was 89 C/C (89%), 11 C/T (11%), and 0 T/T (0%). The distribution of HIF-1alpha genotypes in colorectal cancer patients was 100 C/C (100%), 0 C/T (0%), and 0 T/T (0%). The difference in genotype distribution between patients and control subjects was significant (p<0.0005). These results suggest that the C1772T polymorphism in HIF-1alpha is not involved in progression or metastasis of colorectal carcinoma.
- Published
- 2004
13. No mutations of the Bub1 gene in human gastric and oral cancer cell lines.
- Author
-
Nakagawa H, Yokozaki H, Oue N, Sugiyama M, Ishikawa T, Tahara E, and Yasui W
- Subjects
- Codon, DNA Mutational Analysis, DNA Primers chemistry, DNA, Neoplasm analysis, Exons, Gene Expression Regulation, Neoplastic, Humans, Mouth Neoplasms pathology, Plasmids, Polymorphism, Single-Stranded Conformational, Protein Serine-Threonine Kinases, RNA, Neoplasm metabolism, Reverse Transcriptase Polymerase Chain Reaction, Stomach Neoplasms pathology, Tumor Cells, Cultured, Mouth Neoplasms genetics, Mutation, Protein Kinases genetics, Stomach Neoplasms genetics
- Abstract
Chromosomal instability is one of the most important characteristics underlying tumorigenesis. Certain colorectal cancers with chromosomal instability have been shown to have inactivation of a spindle assembly checkpoint party due to mutation of Bub1, a mitotic checkpoint gene. We performed sequencing analysis on reverse transcriptase-polymerase chain reaction (RT-PCR) product of the Bub1 cDNA (entire coding sequence) from 8 human gastric cancer cell lines. In addition, genomic PCR products of Bub1 exon 8, 10, 12, 15 and kinase domain from 9 oral cancer cell lines were analyzed by polymerase chain reaction-single-stand conformation polymorphism (PCR-SSCP). Although sequencing analysis of the Bub1 cDNA revealed several point mutations in 8 gastric cancer cell lines, we could not confirm the mutations by analyzing genomic DNA. Furthermore, genomic PCR-SSCP analysis revealed no mutations in exon 8, 10, 12, 15 and kinase domain of the Bub1 gene in any oral cancer cell lines examined. These results suggest that mutation of the Bub1 gene might not play a role in human stomach and oral carcinogenesis.
- Published
- 2002
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.